Diabetic Neuropathy Study
Five clinics will be participating in a Phase 3 Double Blind placebo controlled study for the treatment of Diabetic Neuropathy.  Qualified participants will spend 8 - 10 hours a day for 12 to 15 consecutive days, for which they will be paid.  Follow up evaluations immediately following and for 6 months after the procedure will be required. 

Update:  We are no longer accepting study participants for this study.